The experimental results demonstrated that GAs pretreatment could reduce the inflammatory response through inhibiting TLR4/MyD88/NF-kB signaling pathway and alleviate cell apoptosis, which suggests that GAs have the potential to be developed as a preventive agent for preventing RIRI-induced AKI. This evidence concerns the gene TLR4 and acute kidney injury.